RCAG
GMED icon

Rehmann Capital Advisory Group’s Globus Medical GMED Stock Holding History

Rehmann Capital Advisory Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-21
Closed -$908 – 2107
2018
Q4 		$908 Hold
21
– – ﹤0.01% 1669
2018
Q3 		$1.19K Hold
21
– – ﹤0.01% 1946
2018
Q2 		$1.06K Sell
21
-123
-85% -$6.41K ﹤0.01% 1951
2018
Q1 		$7K Buy
+144
New +$6.77K ﹤0.01% 1419

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Rehmann Capital Advisory Group's GMED Position: Q1 2019 in Review

Rehmann Capital Advisory Group sold out of Globus Medical (GMED) in Q1 2019, closing a stake of 21 shares — an estimated $908 sold.

Rehmann Capital Advisory Group first reported a position in GMED in Q1 2018 and held it in 4 quarters. The position peaked at $7K in Q1 2018. 269 funds tracked by Wall St. Rank hold GMED as of Q1 2019.

  • Rehmann Capital Advisory Group reported no remaining Globus Medical position as of Q1 2019 after selling out during the quarter.
  • Rehmann Capital Advisory Group sold 21 Globus Medical shares in Q1 2019, an estimated $908.
  • Rehmann Capital Advisory Group first reported a position in Globus Medical in Q1 2018 and held it in 4 quarters.
  • Rehmann Capital Advisory Group's Globus Medical position peaked at $7K in Q1 2018.
  • 269 funds tracked by Wall St. Rank held Globus Medical as of Q1 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2019, filed 22 May 2019.